News & Events category:
NIHR Manchester Biomedical Research Centre
Researchers urge arthritis patients to give up smoking to help them live longer
Manchester researchers have found new evidence to suggest that people with rheumatoid arthritis who stop smoking, dramatically reduce their risk of earlier death.
Research suggests clinicians should be vigilant in identifying adrenal insufficiency even in patients on low levels of glucocorticoids
Research led by Rebecca Joseph at the NIHR Manchester Musculoskeletal BRU has found evidence that demonstrates adrenal insufficiency at all levels of glucocorticoid exposure, even low dosage.
How to get a fellowship: for aspiring clinical academics
The 4ward North Academy 'How to get a fellowship' meeting for aspiring clinical academics is a great opportunity to meet fellow trainees, leading figures in clinical training and research leaders.
Manchester Regenerative Medicine (MaRM) Network Launch Event 23 May
On Monday 23 May the official launch of the Manchester Regenerative Medicine (MaRM) Network will take place at the Whitworth Art Gallery.
Genetic studies confirm two distinct sub-types of rheumatoid arthritis
A new study by researchers in Manchester has found that anti-CCP negative and positive rheumatoid arthritis are two genetically different disease subclasses.
New research suggests DNA methylation profiling could predict rheumatoid arthritis patient’s response to treatment
A new study has indicated that DNA methylation profiling may provide a method of predicting response to rheumatoid arthritis drug etanercept.
New research suggests association between chronic widespread pain and frailty in older European men
Researchers at the University of Manchester have found that chronic pain is associated with an increased risk of frailty in older men.
Protagen AG joins MATURA Consortium to support Identification of Treatment Response Predictors in Rheumatoid Arthritis
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has today announced that it will join the MATURA Consortium